To amend the Federal Food, Drug, and Cosmetic Act to establish special rules to provide for continued review of human drug and device submissions during a lapse of appropriations, and for other purposes.

119-hr9635 — To amend the Federal Food, Drug, and Cosmetic Act to establish special rules to provide for continued review of human drug and device submissions during a lapse of appropriations, and for other purposes.. Sponsored by Rep. Mullin, Kevin [D-CA-15]. Introduced 2026-07-09. House bill. 119th Congress. Latest action: Referred to the House Committee on Energy and Commerce.

119-hr9635 119th Congress House

Bill Activity

House
Introduced
2026-07-09
Introduced in House
Referred to Committee
Referred to the House Committee on Energy and Commerce.
Committee
2026-07-09
Referred to the House Committee on Energy and Commerce.
Sponsor
Rep. Mullin, Kevin [D-CA-15] (D), CA
Introduced
2026-07-09
Committees
Energy and Commerce Committee
Latest Action
Referred to the House Committee on Energy and Commerce.

No roll-call vote data available for this bill.

Explore This Bill

Investigate this bill → AI summary, roll-call breakdown, and full bill analysis